A Nimbolide-Based Kinase Degrader Preferentially Degrades Oncogenic BCR-ABL
Bingqi Tong(University of California, Berkeley), Daniel K. Nomura(Berkeley College)
Cited by 12
Related Papers
Advances in covalent drug discovery
|Nature Reviews Drug Discovery|2022|757
Deubiquitinase-targeting chimeras for targeted protein stabilization
|Nature Chemical Biology|2022|310
Bardoxolone conjugation enables targeted protein degradation of BRD4
|Scientific Reports|2020|139
Chemoproteomics-enabled discovery of a covalent molecular glue degrader targeting NF-κB
|Cell chemical biology|2023|95